Company: LIMN
Filing Date: 2025-06-24
Form Type: S-1
Source: 0001410578-25-001432
Chunk: 159

Company: Liminatus Pharma, Inc.
Filing Date: 2025-06-24
Form: S-1
Chunk 159
---
 of common stock at the time of this grant. Company will generally be entitled to a deduction at the same time and in the same amount as the income that is required to be included by the U.S. Participant.

A U.S. Participant who receives an unrestricted stock award generally recognizes ordinary compensation income equal to the excess, if any, of the fair market value of such common stock on the date of grant. The Company will generally be entitled to a deduction for such amount.

Director Compensation

We intend to use monthly fees and stock option grants to attract and retain qualified candidates to serve on the Board. This compensation reflected the financial condition of the Company. In setting director compensation, we consider the significant amount of time that directors expend in fulfilling their duties to the Company as well as the skill-level required by our members of the Board.

We do not intend to compensate our non-employee directors.

<div align='center'>101</div>

BENEFICIAL OWNERSHIP OF SECURITIES The following table sets forth information as of June 16, 2025 regarding the beneficial ownership of shares of our Common Stock by:

| ● | each person known by us to be the beneficial owner of more than 5% of the outstanding shares of any class of our voting securities; |

| ● | each of our current executive officers and directors; and |

| ● | all executive officers and directors of the Company as a group. |

Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60 days. Shares of common stock issuable pursuant to options or warrants are deemed to be outstanding for purposes of computing the beneficial ownership percentage of the person or group holding such options or warrants but are not deemed to be outstanding for purposes of computing the beneficial ownership percentage of any other person. Subject to the paragraph above, percentage ownership of ParentCo Common Stock is based on 26,014,633 shares of ParentCo Common Stock outstanding as of the date of this prospectus. The table below does not include the shares of ParentCo Common Stock underlying the Warrants because these securities are not exercisable within 60 days of June 16, 2025. Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all shares of common stock owned by them.

| ​                                                               | ​